Blood disorders in people with angiodysplasia
Part of Blood & lymphatic, Heart & circulation clinical trials.
This trial studies blood disorders in people with angiodysplasia, which are abnormal blood vessels in the digestive tract that can cause bleeding. It aims to understand how these blood vessel problems affect your blood health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have bleeding in your digestive tract (like black or bloody stools, or vomiting blood)
- You have been diagnosed with angiodysplasia (abnormal blood vessels in the gut) by an upper endoscopy or colonoscopy
- You do not have other causes of GI bleeding, such as ulcers or a bleeding disorder like hemophilia
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at blood changes in people who have been diagnosed with angiodysplasia (abnormal blood vessels in the gut) that caused bleeding. By studying these patients, researchers hope to better understand the link between angiodyplasia and blood disorders.
This trial tests whether a special algorithm can reduce repeat bleeding from the gut or nose in people with inherited Von Willebrand disease. If you have had serious nosebleeds or digestive bleeding, this study may help find a better way to manage your condition.
This trial is looking at patients with ischemic heart disease who are taking one or two antiplatelet drugs (like aspirin or clopidogrel) and have had gastrointestinal bleeding. The goal is to study this problem and find better ways to manage it.
This study looks at genes and blood function in people with inherited (passed-down) problems with platelets, white blood cells, or blood clotting. It may help improve understanding of the cause of these conditions and how they work in the body.
This Phase 1/2 study tests VGA039 in healthy adults and people with von Willebrand disease (VWD). The goal is to see if the drug is safe and how it affects bleeding-related factors, especially in people who have symptoms.
This study is testing a new treatment for people with certain types of Von Willebrand disease (Type 1 or 2A) who have frequent bleeding problems. It aims to see if the treatment can help reduce these bleeding episodes.
Hear when a new Angiodysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.